Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Go back to Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics
(NASDAQ: NTLA) Delayed: 12.79 +0.11 (0.87%)
Previous Close $12.68    52 Week High $30.40 
Open $12.59    52 Week Low $11.86 
Day High $12.96    P/E N/A 
Day Low $12.52    EPS $0.00 
Volume 1,564,656